Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Jul 19, 2022 10:15pm
186 Views
Post# 34836045

RE:RE:RE:RE:RE:RE:Question

RE:RE:RE:RE:RE:RE:Question

Gorf79 wrote: How could it be anybody but Baxter?

They have already essentially launched  PMX to shareholders and their sales force.

Honestly, who else will take out PMX?


Maybe Elon. 

only 1/5th the price of Twitter and probably more lucrative in the long run.

but seriously there are other major distributors of medical equipment - just don't ask me to list them. 

the heavy lifting would be done :

-assuming FDA Approval accomplished after 20 years of Trials and $100m spent  ( including FDA approved companion diagnostic) 
- Manufacturing taken care of by Toray 

Simply take orders from ICUs , provide on- line training to Drs. ( who are responsible for reading the label) 
 

<< Previous
Bullboard Posts
Next >>